KOMP2-Phase 2 Production and Phenotyping by the DTCC Consortium
Dr. K.C. Kent Lloyd received a 5 year grant from the Office of the Directory, NIH. The DTCC KOMP2-Phase2 project will create and study knockout mouse models for at least 1,500 human genes. The models and data we produce will significantly add to what we currently know about the normal function of genes in healthy development and life and the consequences of gene dysfunction (also called mutation) that often cause human disease.